Suchergebnisse - "Hammond, Drayton A"

PubPharm (9)

1

Midodrine as an Adjuvant to Intravenous Vasopressor Agents in Adults With Resolving Shock : Systematic Review and Meta-Analysis

enthalten in: Journal of intensive care medicine | 2020

von Hammond, D. | Smith, M. | Peksa, G. | +3

2

Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock

enthalten in: Critical care medicine | 2020

von Roberts, R. | Miano, T. | Hammond, D. | +116

CommentIn: Crit Care Med. 2020 Oct;48(10):1533-1535. - PMID 32925261

3

Narrative Review of Controversies Involving Vasopressin Use in Septic Shock and Practical Considerations

enthalten in: The Annals of pharmacotherapy | 2020

von Der-Nigoghossian, C. | Hammond, D. | Ammar, M.

4

Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock

enthalten in: Journal of intensive care medicine | 2019

von Hammond, D. | Cullen, J. | Painter, J. | +5

5

Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock

enthalten in: Journal of intensive care medicine | 2019

von Hammond, D. | McCain, K. | Painter, J. | +5

6

Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock

enthalten in: The Annals of pharmacotherapy | 2019

von Menich, B. | Miano, T. | Patel, G. | +1

7

Impact of chronic hypertension on time to goal mean arterial pressure and clinical outcomes in critically ill patients with septic shock requiring vasopressors

enthalten in: Journal of critical care | 2019

von Yeo, Q. | Hammond, D. | Li, C. | +1

8

Incidence of Clinically Significant Hypotension Stratified by Vasopressin Duration

enthalten in: Journal of intensive care medicine | 2019

von Hammond, D. | Painter, J. | Meena, N.

9

Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock

enthalten in: Pharmacotherapy | 2018

von Hammond, D. | Ficek, O. | Painter, J. | +6

1
[1]